Printed From BioPortfolio.com
NEXT ARTICLE{Medical News Today via BioPortfolio} The University of Kentucky Markey Cancer Center breast oncologist Dr. Suleiman Massarweh and his research team presented findings from their studies on relapse of breast cancer at the San Antonio Breast Cancer Symposium this month. The two studies aimed to characterize further risk factors for presentation with metastatic disease or risk of early metastatic relapse after initial therapy. Data for each study was collected from 1,089 patients at the UK Markey Cancer Center between January 2007 and May 2011...
Original Article: Researchers Present Findings From Kentucky Breast Cancer Patients With Disease Relapse
Breast Cancer
Breast cancer in the UK is diagnosed in nearly? 46,000 people? each year, with just over 12,000 dying from breast cancer each year in he UK. There are several risk factors for developing b...
Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...
Epithelial cell adhesion molecule (EpCAM; CD326) is a cell surface protein that is frequently expressed at high level on most solid tumor types, including prostate, breast, colon, gastric, ovarian,...
Selective estrogen receptor modulators (SERMs) act as estrogen receptor (ER) agonists or antagonist depending on the targeted tissue and the specific configuration of the used SERM. Effects on bone, e...
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated...
Cancer (malignant neoplasm) is a class of disease. There are malignancy properties that cancer cells have;? 1. The diseased tissue grows uncontrollably, ignoring growth arrest signals,?...
The humanized anti-Her2 monoclonal antibody Herceptin (trastuzumab) has become the mainstay in the treatment of Her2-positive breast cancer. Combining trastuzumab with the potent cytotoxic DM1 via a s...
Associated Content for this Article
Latest News
Biotechnology, Pharmaceutical and Healthcare Reports
Searches Linking to this Page
None
Source: http://c.moreover.com/click/here.pl?r5660151107&f=378
newt gingrich chicago bears margarito margarito horton hears a who horton hears a who cotto margarito
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.